Your Article Summary
Intravitreal bevacizumab for idiopathic choroidal neovascularization
Journal of American Association for Pediatric Ophthalmology and Strabismus , 06/29/09
Cakir M et al. - An otherwise healthy 8-year-old girl with active juxtapapillary choroidal neovascularization was successfully treated with two intravitreal injections of bevacizumab. Intravitreal bevacizumab was well tolerated, choroidal neovascularization involuted, and subretinal and intraretinal serous fluid resorbed, with improvement in visual acuity from 20/400 to 20/50.
Today in Pediatric Ophthalmology...keeping you current
Receive free subspecialty "5-minute updates" via email
Is ethnicity a risk factor for severe retinopathy of prematurity
BMJ - ADC - Fetal and Neonatal, 12/08/09
Long-Term Effectiveness of Treatments for Symptomatic Convergence Insufficiency in Children
Optometry and Vision Science, 12/08/09
Intraoperative Adjustable Suture Surgery for Excyclotorsion: A Modification of the Harada-Ito Procedure
Journal of Pediatric Ophthalmology & Strabismus, 12/03/09

See Latest Articles